Literature DB >> 15064744

Mutation of a CK2 phosphorylation site in cdc25C impairs importin alpha/beta binding and results in cytoplasmic retention.

Sandra L Schwindling1, Andreas Noll, Mathias Montenarh, Claudia Götz.   

Abstract

cdc25C is a phosphatase, which activates the mitosis-promoting factor cyclin B1/cdc2 by dephosphorylation, and thus triggers G(2)/M transition. The activity of cdc25C itself is controlled by phosphorylation of certain amino-acid residues, which among other things determines the subcellular localization of the enzyme. Here, we describe a new phosphorylation site at threonine 236 of cdc25C, which is phosphorylated by protein kinase CK2. This phosphorylation site is located near the nuclear localization signal (amino acids 239-245). We demonstrate that cdc25C interacts with importin beta and the importin alpha/beta heterodimer but not with importin alpha. We further found that a cdc25C phosphorylation mutant where threonine 236 was replaced by aspartic acid as well as cdc25C phosphorylated by CK2 binds importin beta or the importin alpha/beta heterodimer less efficiently than wild type or the corresponding alanine mutant. Furthermore, the cdc25C(T236D) shows a retarded uptake into the nucleus in a cell import assay. Inhibition of protein kinase CK2 enzyme activity in vivo resulted in an enhanced nuclear localization of cdc25C. Thus, phosphorylation of cdc25C at threonine 236 is an important signal for the retention of cdc25C in the cytoplasm.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15064744     DOI: 10.1038/sj.onc.1207566

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  5 in total

1.  Down-regulation of CK2 activity results in a decrease in the level of cdc25C phosphatase in different prostate cancer cell lines.

Authors:  Carolin C Schneider; Claudia Götz; Andrea Hessenauer; Jürgen Günther; Sabine Kartarius; Mathias Montenarh
Journal:  Mol Cell Biochem       Date:  2011-07-13       Impact factor: 3.396

2.  A regulated nucleocytoplasmic shuttle contributes to Bright's function as a transcriptional activator of immunoglobulin genes.

Authors:  Dongkyoon Kim; Philip W Tucker
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

3.  A specific inhibitor of protein kinase CK2 delays gamma-H2Ax foci removal and reduces clonogenic survival of irradiated mammalian cells.

Authors:  Felix Zwicker; Maren Ebert; Peter E Huber; Jürgen Debus; Klaus-Josef Weber
Journal:  Radiat Oncol       Date:  2011-02-10       Impact factor: 3.481

4.  The G2 checkpoint-a node-based molecular switch.

Authors:  Mark C de Gooijer; Arnout van den Top; Irena Bockaj; Jos H Beijnen; Thomas Würdinger; Olaf van Tellingen
Journal:  FEBS Open Bio       Date:  2017-03-04       Impact factor: 2.693

5.  Casein kinase 2 prevents mesenchymal transformation by maintaining Foxc2 in the cytoplasm.

Authors:  D Golden; L G Cantley
Journal:  Oncogene       Date:  2014-12-08       Impact factor: 9.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.